Skip to content

A systematic review on the role of EEG and fMRI-Neurofeedback training in the treatment of substance use disorders and behavioral addiction.

Mazyar Fathi, Mohammad Navid Ebrahimi, Mohammad Banazadeh, Amirreza Shirvani, Nasim Kamalahmadi, Houshang Amiri, Ali Talaei

Psychiatry Research July 1, 2025 DOI: 10.1016/j.psychres.2025.116474 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Systematic review Peer reviewed
Intervention fMRI
Topics Addiction
Keywords Behavioral addiction Substance use disorders FMRI Fnirs, craving Neurofeedback biofeedback Neurotherapy EEG Biofeedback Drug rehabilitation Recovery Brain Imaging EEG Neuroimaging Mental health
Citations 6
Key findings Neurofeedback shows promise as an adjunctive intervention for treating substance use disorders, with reduced drug craving as the primary outcome.

Abstract

Neurofeedback (NF), a form of biofeedback, is used to enhance the self-regulation of brain functions by assessing brain activity and delivering feedback signals to ameliorate emotional attributes, cognitive functions, and behaviors. Despite the potential role of NF in substance use disorder (SUD) treatment, a number of gaps such as variations in NF methods persist. This study aims to address such gaps and present comprehensive insights into EEG and fMRI-NF applications in SUD management. This study has been conducted according to the PRISMA guidelines. The search spanned four major databases: Web of Science, Scopus, PubMed, and Embase. The search terms encompassed "Neurofeedback" OR "EEG biofeedback" OR "neurotherapy" OR "Functional near-infrared spectroscopy Neurofeedback" OR "fNIRS-Neurofeedback" AND addiction OR Drug OR "substance dependence" OR "substance abuse" OR Heroin OR Opioid OR Cannabis OR Marihuana OR Cocaine OR Crack OR Amphetamine OR Methamphetamine OR Hallucinogen. Our systematic review yielded 32 articles, including 18 EEG-, 11 fMRI-neurofeedback, and 3 fNIRS-neurofeedback studies. The primary outcome was reduced drug craving and some aspects of mental health and EEG-NF studies consistently indicated a preference for the alpha-theta protocol, whereas the high heterogeneity among fMRI-NF protocols limited direct comparisons. In conclusion, the results of this systematic review indicate that NF shows promise as an adjunctive intervention for treating SUD.

Comparable studies

Other systematic reviews and meta-analyses on addiction, most cited first.

Study Year Design Participants
Ketamine use: a review Ketamine users 2011 Systematic review
Mindfulness Meditation for Substance Use Disorders: A Systematic Review Individuals with substance use disorders 2009 Systematic review
Mindfulness-Based Interventions for the Treatment of Substance and Behavioral Addictions: A Systematic Review 2018 Systematic review
Ketamine for the treatment of mental health and substance use disorders: comprehensive systematic review 2021 Systematic review
Therapeutic Use of LSD in Psychiatry: A Systematic Review of Randomized-Controlled Clinical Trials Patients with psychiatric disorders, primarily alcoholism 2020 Systematic review n = 567

Citations in the library

Explore topics